On June 18, 2026, the stockholders of the Company approved an amendment and restatement of the Company's Amended and Restated 2000 Long Term Incentive Plan (the "Plan"). The amendment and restatement of the Plan revised the terms and conditions of the Plan to, among other things, increase the shares available for grant under the Plan by 1,000,000 shares. As of September 30, 2026, there were 1,481,230 shares available for the grant of awards under the Plan, assuming maximum performance of performance-based awards.

A summary of the Company’s stock option activity and related information for the nine months ended September 30, 2026 is as follows:


	Options		Weighted- average exercise price		Weighted- average remaining contractual life (years)	Aggregate intrinsic value (in thousands)
Options outstanding, January 1, 2026	827,000		$	11.07

Exercises	(49,375)		5.96

Expirations	(8,500)		15.69
Options outstanding, September 30, 2026(1)	769,125		11.35		3.1	$	199
Options exercisable, September 30, 2026	687,000		$	11.86	2.6	$	51
Total unrecognized stock option expense remaining (in thousands)	$	156
Weighted-average years expected to be recognized over	1.3

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value that would have been received by the option holders had all option holders exercised their exercisable, in-the-money stock options on September 30, 2026. The intrinsic value is calculated for each in-the-money stock option as the difference between the closing price of the Company’s common stock on September 30, 2026 and the exercise price.

A summary of the Company’s restricted stock activity and related information for the nine months ended September 30, 2026 is as follows:


	Restricted Shares		Weighted- average grant date fair value
Non-vested restricted shares, January 1, 2026	885,925		$	6.06
Grants	346,811		4.42
Vested	(486,977)		5.74
Forfeitures	(7,003)		5.99
Non-vested restricted shares, September 30, 2026	738,756		$	5.51
Total unrecognized compensation expense remaining (in thousands)	$	3,074
Weighted-average years expected to be recognized over	1.4

Each performance award represents the right to receive up to 150% of the target number of shares of common stock. The number of shares of common stock earned will be determined at the end of the performance period, based on the attainment of

specified performance goals at the time of grant, as determined by the Compensation Committee of the Company’s board of directors (the “Board of Directors”). The shares are subject to the terms and conditions of the Company’s Plan.

A summary of the Company’s performance-based award activity and related information for the nine months ended September 30, 2026 is as follows:


	Performance- based stock awards (1)		Weighted- average grant date fair value
Non-vested performance-based awards, January 1, 2026	730,797		$	6.70
Grants	259,731		3.07


Forfeitures(2)	(192,530)		5.92
Non-vested performance-based awards, September 30, 2026	797,998		$	5.70
Total unrecognized compensation expense remaining (in thousands)	$	1,458
Weighted-average years expected to be recognized over	1.6

The Company recorded stock compensation expense as follows (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
Stock Compensation Expense Components	2026		2025		2026		2025
Equity based stock option expense	$	28	$	50	$	112	$	184
Restricted and performance-based stock awards expense	873		946		2,803		2,919
Stock compensation expense for equity based awards	901		996		2,915		3,103
Liability based stock option expense	—		(2)		(22)		(3)

Total Stock Compensation Expense	$	901	$	994	$	2,893	$	3,100